Bessie Medical Agrees to $1.67 Million Settlement Over Anti-Kickback and False Claims Allegations

ASD Specialty Healthcare LLC, which operates as Besse Medical, has agreed to pay $1.67 million to settle claims that it broke the Anti-Kickback Statute and the False Claims Act, as reported by the U.S. Department of Justice (DOJ).

Carrollton, Texas, based Besse Medical, specializes in medical and pharmacy products all over the nation. One of their more significant roles involves the distribution of eye injections for the treatment of neovascular age-related macular degeneration (wet AMD), a leading cause of vision loss in the elderly.

The accusations against Besse Medical involved giving free inventory management systems to eye care practices. These systems were reportedly offered to encourage the practices to buy certain drugs, especially those used for treating eye conditions, from Besse Medical.

The DOJ says these actions might sway what people buy and harm fair competition. This breaks federal healthcare laws that stop illegal payments and keep the market fair.

The person who reported this used to work for a drug company. The case against Besse Medical is linked to bigger cases about companies pushing treatments for wet AMD to eye doctors.

These events show how important it is for drug companies to follow the rules and watch how their distributors work. They remind us that marketing plans can have legal consequences and that being open and honest with healthcare providers is key to keeping federal healthcare programs trustworthy.

 


Powered by


No, thank you. I do not want.
100% secure your website.